PharmaShots | Incisive News in 3 Shots

Subscribe Now

Type 1 HIV-1 infection

ViiV's Cabenuva (cabotegravir and rilpivirine) Receives the US FDA's Approval as the First and Only Complete Long-Acting Regimen for HIV treatment

ViiV's Cabenuva (cabotegravir and rilpivirine) Receives the US FDA's Approval as the First and Only Complete Long-Acting Regimen f...

January 22, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us